Connect your AI

OS Therapies OSTX Tax Credit Carryforward Valuation Allowance

Tax Credit Carryforward Valuation Allowance at other companies

Sharplink, Inc. SBET

$160.84M+2,253%

Oaktree Specialty LendingOCSL

$6.4M-28.9%

Ryan Specialty HoldingsRYAN

$0—

Unusual MachinesUMAC

$5.82M+85.5%

Peapack-Gladstone FinancialPGC

$1.55M0.0%

Trex CompanyTREX

$2.2M-15.4%

Other financials

Income statement

Operating income-$10.2M-103%

Net income-$10.4M-168%

EPS (diluted)-$0.27-50.0%

Balance sheet

Cash & equivalents$917.6K-69.1%

Total debt$20.0M—

Total equity-$10.8M-159%

Total assets$7.3M+71.7%

Cash flow

Operating cash flow-$4.6M-32.6%

CapEx$316.4K—

Free cash flow-$3.7M—

Valuation

Market cap$84.62M+65.5%

Enterprise value$103.7M—

Returns & leverage

Return on equity470%—

Debt / equity-1.8×—

Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:TaxCreditCarryforwardValuationAllowance.

The official record: OS Therapies’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's tax credit carryforward valuation allowance.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is OS Therapies's tax credit carryforward valuation allowance?: OS Therapies (OSTX) reported tax credit carryforward valuation allowance of $13.21M in Q4 2025.